PubMed Health⌕ Search

Biomedical subjects

Y Eshdat

Publications and source records attributed to Y Eshdat.

15 recordsLinked to original sources
PubMed1990

Localization and characterization of three different beta-adrenergic receptors expressed in Escherichia coli.

After fusion with the N-proximal portion of the outer membrane protein LamB, three beta-adrenergic receptors, the human beta 1- and beta 2- and turkey beta 1-adrenergic receptor, were expressed in Escherichia coli with retention of their own specific pharmacological properties. Molecular characterization and localization of the three receptors in bacteria and comparison of the behaviour of each hybrid protein are reported. The bacteria were lysed and fractionated on a sucrose gradient. Saturable [125I]iodocyanopindolol binding activity was found associated mainly with the inner membrane fraction, suggesting that the receptor is correctly folded in this membrane. Binding activity was also found in the outer membrane fraction but varied according to the receptor type. Photoaffinity labeling experiments revealed that the receptors exhibit binding activity only after proteolytic removal of the LamB moiety from the fusion protein. The three hybrid proteins, detected in immunoblots by anti-peptide antibodies, were found mainly in the outer membrane fraction. Each of them exhibited different susceptibility to intrinsic bacterial proteolytic enzymes; sites of proteolytic cleavage were localized by the use of anti-peptide antibodies. The functional expression in E. coli of three beta-adrenergic receptors with similar structure but different amino acid sequences suggests that this expression system may be a general feature among similar receptors of the family of G-protein-coupled receptors. The level of expressed binding activity of a given receptor will be within the control of proteolytic degradation processes, depending on the primary sequence of the receptor. Constructions of new hybrid proteins, in combination with expression in protease mutants of E. coli, should help in controlling such processes.

Animals↗
PubMed1989

Chemical characterization of ligand binding site fragments from turkey beta-adrenergic receptor.

Affinity-labeled beta-adrenergic receptor from turkey erythrocyte membranes was specifically cleaved near cysteine residues after S-cyanylation. Analysis of the labeled polypeptide fragments suggests that iodocyanopindolol diazirine reacted with an amino acid residue which is located in the non-glycosylated region containing the sixth and seventh transmembrane domains of the receptor. However, the possibility cannot be excluded that a second residue, located between the third and fifth transmembrane domains, was also labeled. Since treatment with either hydroxylamine or triethylamine resulted in removal of the affinity label from the protein, the present study suggests that aspartic or glutamic acid residues are present in the adrenergic-binding site which is located in the above-mentioned domains. The procedure for specific chemical cleavage of the affinity-labeled adrenergic receptor should also be useful for future structural and comparative studies of other adrenergic receptors.

Affinity Labels↗
PubMed1988

Human beta 2-adrenergic receptors expressed in Escherichia coli membranes retain their pharmacological properties.

The coding region of the gene for the human beta 2-adrenergic receptor gene was fused to the beta-galactosidase gene of the lambda gt11 expression vector. The Y1089 Escherichia coli strain was lysogenized with this modified vector and transcription of the fusion gene was induced. Expression of this transcription unit was shown by the appearance in the bacteria of proteins of molecular weight higher than that of native beta-galactosidase, which are immunoreactive with anti-beta-galactosidase antibodies. Production of beta 2-adrenergic receptors was shown by the presence, on intact bacteria, of binding sites for catecholamine agonists and antagonists possessing a typical beta 2-adrenergic pharmacological profile. Binding and photoaffinity labeling studies performed on intact E. coli and its membrane fractions showed that these binding sites are located in the inner membrane of the bacteria. Expression of pharmacologically active human beta 2-adrenergic receptors in E. coli further supports the similar transmembrane organization proposed for bacteriorhodopsin and eukaryotic membrane-embedded receptors coupled to guanine nucleotide-binding regulatory proteins. Moreover, this system should facilitate future analyses of the ligand-binding properties within this family of membrane receptors.

Affinity Labels↗
PubMed1979

Specific fragmentation of human erythrocyte spectrin by chemical cleavage at cysteine residues.

Spectrin, isolated from human erythrocyte membrane, was specifically cleaved at the amino side of its cysteine residues by reacting it with 2-nitro-5-thiocyanobenzoic acid at pH 8.0 and incubating the product at pH 9.0. Conditions were developed to obtain quantitative cleavage, with virtually no side reactions due to exposure to the alkaline pH. The solubility and aggregation state of the spectrin fragments in 0.2 M sodium chloride, in 7 M guanidine hydrochloride or in 10 M urea, at pH 8.0, allow separation and partial purification of the fragments by gel filtration or by ion-exchange chromatography. Our results strongly suggest that various parts of the spectrin molecules have similar amino acid compositions. Due to the relatively limited number of fragments, this cleavage method is a promising tool for further elucidation of the structure of spectrin and for understanding its role in the erythrocyte membrane.

Amino Acids↗
PubMed1979

Substructure of human erythrocyte spectrin.

The human erythrocyte structural protein spectrin and its subunits I, II were isolated in the presence of Na-dodecyl-sulfate by gel filtration and preparative gel electrophoresis. After removal of the detergent, spectrin alpha-helical content is comparable to spectrin isolated without detergent. Subunits I and II formed single bands in isoelectric focusing (pI = 5.6) and in Ornstein-Davis disc gel electrophoresis systems, indicating the individual subunits are homogenous in nature. The molecular weights of the subunits I and II, determined by Ferguson plot, are 237,500 and 238,600, respectively, which is in good agreement with values obtained by the standard SDS gel relative mobility method. Limited tryptic digestion of spectrin and two-dimensional peptide maps of the individual subunits cleaved by S-cyanylation reaction showed dissimilar patterns, suggesting differences in primary structure between the two subunits.

Amino Acids↗
PubMed1977

Lysozyme.

Explore the source record for details and available documents.

Acetylglucosamine↗
PubMed1977

Colonic tumor membrane-associated glycoprotein: isolation of antigenically-active peptides after chemical cleavage.

A membrane-associated glycoprotein fraction, referred to a CEA-M was isolated from human colonic tumor tissue by sodium dodecyl sulfate extraction of membrane fragments followed by wheat germ agglutinin affinity chromatography, Bio-Gel A-1.5 gel filtration and preparative slab gel electrophoresis. With a m.w. of approximately 200,000, isoelectric point of about 4.2 and carbohydrate:protein ratio of 2:1, this glycoprotein has physiocochemical and antigenic similarities to carcinoembryonic antigen, CEA. Immunochemical studies have shown that antiserum developed for this glycoprotein possesses relative specificity for human colonic carcinomas. Chemical cleavage of this glycoprotein by 2-nitro-5-thiocyanobenzoic acid resulted in three major Coomassie Blue and two periodic acid Schiff stainable fragments (one of which stains with both). It was found that one of the glycopeptides, labeled as TA, isolated by affinity and covalent chromatography, contained 77% carbohydrates and possessed antigenic determinants recognized by at least 70% of the antibody population raised against the total glycoprotein fraction; purified antibodies to this region of the molecule seem promising for the development of a specific assay for gastrointestinal tumors.

Antibodies, Neoplasm↗
PubMed1974

Chemical conversion of aspartic acid 52, a catalytic residue in hen egg-white lysozyme, to homoserine.

Hen egg-white lysozyme (EC 3.2.1.17) was specifically esterified at aspartic acid 52 by the affinity labeling reagent 2',3'-epoxypropyl beta-glycoside of di-(N-acetyl-D-glucosamine) [Eshdat et al. (1973) J. Biol. Chem.248, 5892]. The disulfide bonds of the affinity-labeled enzyme and the aspartic acid 52-ester bond were reduced with dithiothreitol and sodium borohydride, respectively, resulting in the removal of the affinity label. The reduced protein contained 0.9 mole of homoserine and 1 mole less of aspartic acid per mole of protein, as compared to the native enzyme. It was reoxidized by a mixture of reduced and oxidized glutathione to yield a modified protein that possessed one-tenth of the activity of native lysozyme (presumably due to a contamination by regenerated lysozyme formed as a result of hydrolysis of the aspartic acid 52-ester bond during the chemical treatment). The native enzyme, after reduction and reoxidation in the same manner, retained its amino-acid composition, full enzymatic activity, and fluorescence properties. The modified lysozyme, containing homoserine 52, showed the same fluorescence spectrum as the native enzyme. With both proteins, the fluorescence maximum shifted to the blue to a similar extent upon the addition of the saccharide inhibitors tri-(N-acetyl-D-glucosamine) and the cell-wall tetrasaccharide (GlcNAc-MurNAc)(2). The modified enzyme bound these two saccharides with nearly the same binding constants as those found for native lysozyme and for lysozyme that was reduced and reoxidized. Since the side chain of homoserine is similar in size to that of aspartic acid, it is concluded that the loss of enzymatic activity is the direct result of the chemical modification of the carboxyl side chain of aspartic acid 52, thus showing that this amino acid is essential for the catalytic action of the enzyme.

Amino Acid Sequence↗